Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market size and forecast • Five forces analysis PART 06: Market segmentation by technology • Market overview • FISH • CISH PART 07: Market segmentation by end-user • Market overview • Molecular diagnostic laboratories • Pharmaceutical and biotechnology companies • Others PART 08: Geographical segmentation • Market overview • ISH market in Americas • ISH market in EMEA • ISH market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Increasing M&A activity in molecular diagnostics market • National initiatives across the globe spurring molecular research activities • Increasing importance of promotional activities PART 12: Vendor landscape • Competitive scenario • Investment opportunity PART 13: Key vendor analysis • Abbott • Agilent Technologies • F. Hoffmann-La Roche • Thermo Fisher Scientific • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Differences between CISH and FISH Exhibit 02: Snapshot: Overview of global ISH market Exhibit 03: Global ISH market 2016-2021 ($ millions) Exhibit 04: Factors affecting global ISH market and their level of impact Exhibit 05: Five forces analysis Exhibit 06: Global ISH market by technology 2016 and 2021 (% share) Exhibit 07: Snapshot: Overview of global ISH market by technology Exhibit 08: Global FISH market 2016-2021 ($ millions) Exhibit 09: Global CISH market 2016-2021 ($ millions) Exhibit 10: Global ISH market by end-user 2016 and 2021 (% share) Exhibit 11: Snapshot: Overview of global ISH market by end-user Exhibit 12: Global ISH market by molecular diagnostic laboratories 2016-2021 ($ millions) Exhibit 13: Global ISH market by pharmaceutical and biotechnology companies 2016-2021 ($ millions) Exhibit 14: Global ISH market by others 2016-2021 ($ millions) Exhibit 15: Global ISH market by geography 2016 and 2021 (% share) Exhibit 16: Snapshot: Overview of global ISH market by geography Exhibit 17: ISH market in Americas 2016-2021 ($ millions) Exhibit 18: ISH market in EMEA 2016-2021 ($ millions) Exhibit 19: ISH market in APAC 2016-2021 ($ millions) Exhibit 20: List of FDA-approved companion diagnostic tests using ISH Exhibit 21: Personalized medicine and key statistics from FDA approvals of NMEs Exhibit 22: Advantages of FISH in detection of foodborne pathogens as compared with conventional methods Exhibit 23: Head-to-head comparison between traditional FISH and DMI Exhibit 24: Strategic success factors currently being followed by vendors Exhibit 25: Investment opportunity mapping Exhibit 26: Abbott: Profile Exhibit 27: Abbott: Strength analysis Exhibit 28: Abbott: Strategy assessment Exhibit 29: Abbott: Opportunity assessment Exhibit 30: Agilent Technologies: Profile Exhibit 31: Agilent Technologies: Strength analysis Exhibit 32: Agilent Technologies: Strategy assessment Exhibit 33: Agilent Technologies: Opportunity assessment Exhibit 34: F. Hoffmann-La Roche: Profile Exhibit 35: F. Hoffmann-La Roche: Strength analysis Exhibit 36: F. Hoffmann-La Roche: Strategy assessment Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment Exhibit 38: Thermo Fisher Scientific: Profile Exhibit 39: Thermo Fisher Scientific: Strength analysis Exhibit 40: Thermo Fisher Scientific: Strategy assessment Exhibit 41: Thermo Fisher Scientific: Opportunity assessment

Abbott, Agilent Technologies, F. Hoffmann-La Roche, Thermo Fisher Scientific, Advanced Cell Diagnostics, Biocare Medical, Bio SB, BioDot, BioGenex, Cytocell, Exiqon, Genemed Biotechnologies, LGC Biosearch Technologies, Leica Biosystems, Merck, Mirius Bio, and PerkinElmer.